{"transactions":[{"id":2482660,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-07T21:30:32.000Z","date":"2021-12-03","kind":"other","acquired":false,"shares":24172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":1261,"source":{"system":"sec-edgar","filing":"0000899243-21-047117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924321047117/doc4.xml","form_type":"4"}},{"id":2482659,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-07T21:30:32.000Z","date":"2021-12-03","kind":"other","acquired":false,"shares":49730,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities were held by Co-Investment IV."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000899243-21-047117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924321047117/doc4.xml","form_type":"4"}},{"id":2482658,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2021-12-07T21:30:32.000Z","date":"2021-12-03","kind":"other","acquired":false,"shares":750270,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Fund IV."}],"balance_after":1510521,"source":{"system":"sec-edgar","filing":"0000899243-21-047117","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924321047117/doc4.xml","form_type":"4"}},{"id":2963110,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-12-02T02:36:43.000Z","date":"2020-12-01","kind":"other","acquired":false,"shares":43537,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Represents a transfer, without the payment of any consideration, to an affiliate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Represents a transfer, without the payment of any consideration, to an affiliate."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"Includes 2,260,791 shares of common stock held by Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and 49,730 shares of common stock held by Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\"). Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Fund IV and Co-Investment IV are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":2310521,"source":{"system":"sec-edgar","filing":"0000899243-20-032411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320032411/doc4.xml","form_type":"4"}},{"id":3037879,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-05T01:09:21.000Z","date":"2020-09-04","kind":"other","acquired":false,"shares":45460,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":43537,"source":{"system":"sec-edgar","filing":"0000899243-20-024411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320024411/doc4.xml","form_type":"4"}},{"id":3037878,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-05T01:09:21.000Z","date":"2020-09-04","kind":"other","acquired":false,"shares":31650,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Co-Investment IV."}],"balance_after":49730,"source":{"system":"sec-edgar","filing":"0000899243-20-024411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320024411/doc4.xml","form_type":"4"}},{"id":3037877,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-09-05T01:09:21.000Z","date":"2020-09-04","kind":"other","acquired":false,"shares":1468350,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Fund IV."}],"balance_after":2260791,"source":{"system":"sec-edgar","filing":"0000899243-20-024411","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320024411/doc4.xml","form_type":"4"}},{"id":3052622,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T23:40:59.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":7303,"price":107.64,"value":786094.92,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":42875,"source":{"system":"sec-edgar","filing":"0000899243-20-022972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/doc4.xml","form_type":"4"}},{"id":3052621,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T23:40:59.000Z","date":"2020-08-18","kind":"sale","acquired":false,"shares":10197,"price":110.03,"value":1121975.91,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":50178,"source":{"system":"sec-edgar","filing":"0000899243-20-022972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/doc4.xml","form_type":"4"}},{"id":3052620,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-08-19T23:40:59.000Z","date":"2020-08-17","kind":"sale","acquired":false,"shares":12500,"price":110.73,"value":1384125.0,"ownership":{"direct":true},"footnotes":[{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":60375,"source":{"system":"sec-edgar","filing":"0000899243-20-022972","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320022972/doc4.xml","form_type":"4"}},{"id":3130872,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:51:16.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":44903,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."}],"balance_after":72875,"source":{"system":"sec-edgar","filing":"0000899243-20-014567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320014567/doc4.xml","form_type":"4"}},{"id":3130871,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:51:16.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":6772,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Co-Investment IV."}],"balance_after":81380,"source":{"system":"sec-edgar","filing":"0000899243-20-014567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320014567/doc4.xml","form_type":"4"}},{"id":3130870,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2020-05-29T20:51:16.000Z","date":"2020-05-27","kind":"other","acquired":false,"shares":360561,"price":0,"value":0.0,"ownership":{"direct":false,"nature":"See Footnotes"},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"shares","element":"transactionShares","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F4","text":"Represents transfers, without the payment of any consideration, to their partners and employees."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Fund IV."}],"balance_after":3729141,"source":{"system":"sec-edgar","filing":"0000899243-20-014567","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924320014567/doc4.xml","form_type":"4"}},{"id":3342406,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-13T19:18:55.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":25320,"price":105.47,"value":2670500.4,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F3","text":"The securities are held by Co-Investment IV."}],"balance_after":88152,"source":{"system":"sec-edgar","filing":"0000899243-19-029139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924319029139/doc4.xml","form_type":"4"}},{"id":3342405,"issuer":{"id":3441,"kind":"organization","name":"MADRIGAL PHARMACEUTICALS, INC.","symbol":"MDGL"},"owners":[{"id":132760,"kind":"organization","name":"BAY CITY CAPITAL LLC","position":1,"cik":"0001288452","reported_name":"BAY CITY CAPITAL LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132761,"kind":"organization","name":"Bay City Capital Management IV LLC","position":2,"cik":"0001359070","reported_name":"Bay City Capital Management IV LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132762,"kind":"organization","name":"Bay City Capital Fund IV, L.P.","position":3,"cik":"0001360243","reported_name":"Bay City Capital Fund IV, L.P.","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}},{"id":132763,"kind":"organization","name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","position":4,"cik":"0001333817","reported_name":"BAY CITY CAPITAL FUND IV CO INVESMENT FUND LP","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2019-12-13T19:18:55.000Z","date":"2019-12-13","kind":"sale","acquired":false,"shares":1174680,"price":105.47,"value":123893499.6,"ownership":{"direct":false,"nature":"See Footnote"},"footnotes":[{"field":"ownership.nature","element":"natureOfOwnership","label":"F1","text":"Bay City Capital LLC, a Delaware limited liability company (\"BCC\"), Bay City Capital Management IV LLC, a Delaware limited liability company (\"Management IV\"), Bay City Capital Fund IV, L.P., a Delaware limited partnership (\"Fund IV\"), and Bay City Capital Fund IV Co-Investment Fund, L.P., a Delaware limited partnership (\"Co-Investment IV\") are deemed to be a \"group\" for the purposes of Section 13(d) under the Securities Exchange Act of 1934. Management IV is the general partner of Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV. BCC, the manager of Management IV, is also an advisor to Fund IV and Co-Investment IV and has sole voting and dispositive power with respect to the securities held by Fund IV and Co-Investment IV."},{"field":"ownership.nature","element":"natureOfOwnership","label":"F2","text":"The securities are held by Fund IV."}],"balance_after":4089702,"source":{"system":"sec-edgar","filing":"0000899243-19-029139","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1157601/000089924319029139/doc4.xml","form_type":"4"}}]}